Prevalence and Characteristics of Patients with Cystic Fibrosis-Related Diabetes in Croatia
Open Access
Abstract
This study investigated the prevalence of cystic fibrosis-related diabetes (CFRD) in the Croatian cystic fibrosis (CF) population, the age at diagnosis, insulin requirements, and the relationship between age at diagnosis and other clinical parameters. Medical records from 152 patients with genetically and laboratory-confirmed CF were reviewed through to 2025. The American Diabetes Association criteria were used to diagnose CFRD. Anthropometric and clinical data were collected from the latest medical records. A total of 17 out of 152 patients had CFRD, with a prevalence of 4.8% in the paediatric population (4/84) and 19.1% in adults (13/68). The median age of CFRD diagnosis was 14 years (range 9–22 years, SD = 3.95). Thirteen patients used insulin: one used bolus only, seven used basal-bolus multiple daily injections, and five used insulin pumps. The average total daily insulin (TDI) per kilogram (kg) body weight was 0.447 U/kg (SD = 0.429). The age at CFRD diagnosis was positively correlated with the body mass index (BMI) (p = 0.029). Patients requiring insulin by age 15 had higher TDI and were more likely to have CF liver disease (p = 0.027, p = 0.037, respectively). The prevalence of CFRD and age at diagnosis aligned with previous studies. Patients diagnosed at a younger age and requiring insulin earlier had lower BMIs, likely due to a faster decline in beta cell function and earlier onset of insulinopenia.Keywords
This publication has 36 references indexed in Scilit:
- Cystic fibrosis related liver disease and endocrine considerationsJournal of Clinical & Translational Endocrinology, 2021
- Effect of CFTR modulator therapy on cystic fibrosis-related diabetesJournal of Diabetes and its Complications, 2021
- Cystic fibrosis related diabetes in Europe: Prevalence, risk factors and outcome; Olesen et alJournal of Cystic Fibrosis, 2020
- The association of pediatric cystic fibrosis-related diabetes screening on clinical outcomes by center: A CF patient registry studyJournal of Cystic Fibrosis, 2020
- Disease progression in patients with cystic fibrosis treated with ivacaftor: Data from national US and UK registriesJournal of Cystic Fibrosis, 2020
- Cystic fibrosis related diabetes: Nutrition and growth considerationsJournal of Cystic Fibrosis, 2019
- Cystic fibrosis related diabetes: Pathophysiology, screening and diagnosisJournal of Cystic Fibrosis, 2019
- Insulin Regulation of Proteostasis and Clinical ImplicationsCell Metabolism, 2017
- Retinal screening of patients with cystic fibrosis-related diabetes in Wales — A real eye openerJournal of Cystic Fibrosis, 2015
- Airway glucose concentrations and effect on growth of respiratory pathogens in cystic fibrosisJournal of Cystic Fibrosis, 2007